10-95042980-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000770.3(CYP2C8):​c.1059C>T​(p.His353His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00553 in 1,614,018 control chromosomes in the GnomAD database, including 202 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 191 hom. )

Consequence

CYP2C8
NM_000770.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.775

Publications

8 publications found
Variant links:
Genes affected
CYP2C8 (HGNC:2622): (cytochrome P450 family 2 subfamily C member 8) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 10-95042980-G-A is Benign according to our data. Variant chr10-95042980-G-A is described in ClinVar as [Benign]. Clinvar id is 775289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.775 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0037 (564/152270) while in subpopulation SAS AF = 0.0498 (240/4822). AF 95% confidence interval is 0.0446. There are 11 homozygotes in GnomAd4. There are 332 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2C8NM_000770.3 linkc.1059C>T p.His353His synonymous_variant Exon 7 of 9 ENST00000371270.6 NP_000761.3 P10632-1
CYP2C8NM_001198853.1 linkc.849C>T p.His283His synonymous_variant Exon 7 of 9 NP_001185782.1 P10632B7Z1F5
CYP2C8NM_001198855.1 linkc.849C>T p.His283His synonymous_variant Exon 8 of 10 NP_001185784.1 P10632B7Z1F5
CYP2C8NM_001198854.1 linkc.753C>T p.His251His synonymous_variant Exon 6 of 8 NP_001185783.1 P10632-2B7Z1F5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2C8ENST00000371270.6 linkc.1059C>T p.His353His synonymous_variant Exon 7 of 9 1 NM_000770.3 ENSP00000360317.3 P10632-1

Frequencies

GnomAD3 genomes
AF:
0.00369
AC:
562
AN:
152152
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.0179
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0493
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00279
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00882
AC:
2217
AN:
251478
AF XY:
0.0113
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.0172
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.00323
Gnomad OTH exome
AF:
0.00929
GnomAD4 exome
AF:
0.00572
AC:
8355
AN:
1461748
Hom.:
191
Cov.:
32
AF XY:
0.00734
AC XY:
5334
AN XY:
727176
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33474
American (AMR)
AF:
0.00197
AC:
88
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
461
AN:
26134
East Asian (EAS)
AF:
0.000252
AC:
10
AN:
39698
South Asian (SAS)
AF:
0.0502
AC:
4334
AN:
86256
European-Finnish (FIN)
AF:
0.000112
AC:
6
AN:
53420
Middle Eastern (MID)
AF:
0.0253
AC:
146
AN:
5768
European-Non Finnish (NFE)
AF:
0.00254
AC:
2823
AN:
1111888
Other (OTH)
AF:
0.00782
AC:
472
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
471
943
1414
1886
2357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00370
AC:
564
AN:
152270
Hom.:
11
Cov.:
32
AF XY:
0.00446
AC XY:
332
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41548
American (AMR)
AF:
0.00196
AC:
30
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0179
AC:
62
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0498
AC:
240
AN:
4822
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10600
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00279
AC:
190
AN:
68022
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00406
Hom.:
21
Bravo
AF:
0.00254
Asia WGS
AF:
0.0190
AC:
65
AN:
3478
EpiCase
AF:
0.00480
EpiControl
AF:
0.00480

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 16, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.10
DANN
Benign
0.27
PhyloP100
-0.78
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11188150; hg19: chr10-96802737; COSMIC: COSV104428898; COSMIC: COSV104428898; API